Skip to main content

CORRECTION article

Front. Pharmacol., 09 May 2023
Sec. Inflammation Pharmacology
Volume 14 - 2023 | https://doi.org/10.3389/fphar.2023.1197442

Corrigendum: Clostridium butyricum protects against pancreatic and intestinal injury after severe acute pancreatitis via downregulation of MMP9

This article is a correction to:

  1. Clostridium butyricum Protects Against Pancreatic and Intestinal Injury After Severe Acute Pancreatitis via Downregulation of MMP9

    1. Read original article
Qingqing Yan,Qingqing Yan1,2Lin Jia, Lin Jia1,2*Biyan Wen,Biyan Wen1,2Yao WuYao Wu3Yanbo ZengYanbo Zeng4Qing Wang,Qing Wang1,2
  • 1Department of Gastroenterology, Guangzhou First People’s Hospital, South China University of Technology, Guangzhou, China
  • 2Department of Gastroenterology, The Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou, China
  • 3Department of Gastroenterology, The First Affiliated Hospital of Nan Chang University, Nanchang, China
  • 4Department of Gastroenterology, Changhai Hospital, Shanghai, China

A Corrigendum on
Clostridium butyricum protects against pancreatic and intestinal Injury after severe acute pancreatitis via downregulation of MMP9

by Jia L, Yan Q, Wen B, Wu Y, Zeng Y and Wang Q (2022). Front. Pharmacol. 13:919010. doi: 10.3389/fphar.2022.919010

In the published article, there was an error in the Funding statement. “The funding statement for the Guangzhou Technology Projects was displayed as “No.202102020099”. The original text is that This study was supported by grants from the National Natural Science Foundation of China (No. 81870438) and the Guangzhou Technology Projects (No. 202102020099).” The correct Funding statement appears below.

“Funding

This study was supported by grants from The National Natural Science Foundation of China (No.81870438) and the Guangzhou Technology Projects (No.202102080099).”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: severe acute pancreatitis, Clostridium butyricum, gut microbiota, matrix metallopeptidase 9, intestinal, injury

Citation: Yan Q, Jia L, Wen B, Wu Y, Zeng Y and Wang Q (2023) Corrigendum: Clostridium butyricum protects against pancreatic and intestinal injury after severe acute pancreatitis via downregulation of MMP9. Front. Pharmacol. 14:1197442. doi: 10.3389/fphar.2023.1197442

Received: 31 March 2023; Accepted: 17 April 2023;
Published: 09 May 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Yan, Jia, Wen, Wu, Zeng and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Lin Jia, 13925012853@139.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.